You have read all your free articles, to continue reading subscribe to read the rest of this content.
We asked the CEO of Herantis Pharma, Pekka Simula, about what is in their pipeline right now, about their strategy to reach market and about patient-driven innovation. Herantis Pharma was created by a merger of two pharma companies, Hermo Pharma and Laurantis Pharma. It has a broad product portfoAlready a…
Life science and biotechnology companies require a steady stream of capital and more are entering the stock exchanges to increase their visibility and find investors. NASDAQ Nordic is now one of Europe’s largest biotech hubs, according to Carsten Borring, head of listings and capital markets Already a subscriber Login You have read…
Jonas Hansson is a Venture Partner at HealthCap, a European venture capital firm investing exclusively and globally in life sciences. What kind of companies are you and your colleagues focusing your investments on? And what stages? “We invest in companies/assets in the precision medicine (Already a subscriber Login You have…
DoMore Diagnostics, one of our NLS Stars 2022, aims to change the one-size-fits-all approach in cancer therapy. Cancer is a growing global public health problem, and the cost of cancer care is expected to double the next 20 years. It is a leading cause of death worldwide and accounted for…
